Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort

A. Husing, R. T. Fortner, Tilman Kuhn, K. Overvad, A. Tjonneland, A. Olsen, M. C. Boutron-Ruault, G. Severi, A. Fournier, H. Boeing, A. Trichopoulou, V. Benetou, P. Orfanos, G. Masala, V. Pala, R. Tumino, F. Fasanelli, S. Panico, H. B. Bueno de Mesquita, P. H. PeetersC. H. van Gills, J. R. Quiros, A. Agudo, M. J. Sanchez, M. D. Chirlaque, A. Barricarte, P. Amiano, K. T. Khaw, R. C. Travis, L. Dossus, P. Ferrari, M. A. Merritt, I. Tzoulaki, E. Riboli, R. Kaaks

Research output: Contribution to journalArticle

9 Citations (Scopus)
Original languageEnglish
Pages (from-to)4181-89
Number of pages9
JournalClinical Cancer Research
Issue number15
DOIs
Publication statusPublished - 01 Aug 2017

Cite this

Husing, A., Fortner, R. T., Kuhn, T., Overvad, K., Tjonneland, A., Olsen, A., Boutron-Ruault, M. C., Severi, G., Fournier, A., Boeing, H., Trichopoulou, A., Benetou, V., Orfanos, P., Masala, G., Pala, V., Tumino, R., Fasanelli, F., Panico, S., Bueno de Mesquita, H. B., ... Kaaks, R. (2017). Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort. Clinical Cancer Research, (15), 4181-89. https://doi.org/10.1158/1078-0432.CCR-16-3011.